Dr. Krishna Komandurai | CureTalks
Dr. Komanduri is Medical Director of the hematopoietic stem cell transplant program at the University of Miami Sylvester Cancer Center, one of the fastest growing programs in the country. His laboratory efforts are focused in translational research in T cell immunology and transplantation. Dr. Komanduri served as ASBMT Scientific Chair for the 2015 Tandem meetings, he is past permanent member of the NIH Transplantation, Tolerance and Tumor Immunology study section and current Chair of the ASH scientific committee on Immunology and Host Defense. He is a member of the ASBMT committees on education and reimbursement, and Vice-Chair of the National Marrow Donor Program Advisory Group on Financial Barriers to Transplant Care.
The role of allogeneic stem-cell transplantation is evolving in the paradigm of myeloma treatment. Despite its therapeutic potential of a myeloma cure, the…